Private Advisor Group LLC Sells 643 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Private Advisor Group LLC decreased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 4.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 14,267 shares of the medical equipment provider's stock after selling 643 shares during the period. Private Advisor Group LLC's holdings in Intuitive Surgical were worth $7,447,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of ISRG. Berbice Capital Management LLC bought a new position in Intuitive Surgical in the 4th quarter valued at $26,000. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the 4th quarter worth about $36,000. Sierra Ocean LLC acquired a new stake in Intuitive Surgical in the 4th quarter valued at about $40,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical in the 3rd quarter valued at about $38,000. Institutional investors own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded down $19.98 on Tuesday, hitting $571.03. The company had a trading volume of 1,489,293 shares, compared to its average volume of 1,708,256. The stock has a 50-day moving average of $566.43 and a 200-day moving average of $526.49. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The firm has a market capitalization of $203.39 billion, a P/E ratio of 88.81, a P/E/G ratio of 5.85 and a beta of 1.39.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company's stock, valued at $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Jamie Samath sold 188 shares of the company's stock in a transaction dated Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $101,332.00. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,720,023. This represents a 2.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 6,240 shares of company stock valued at $3,529,040. 0.80% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research analyst reports. Stifel Nicolaus increased their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a research note on Thursday, December 5th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $630.00 to $687.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Leerink Partners upped their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Finally, Jefferies Financial Group lifted their price objective on Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have issued a buy rating to the stock. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.